ArticleAMB Express2026
Host-associated bioprospecting from Opisina arenosella: a Beauveria bassiana isolate against red palm weevil.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Host-associated bioprospecting of naturally infected insects provides a valuable approach for recovering indigenous entomopathogenic microorganisms adapted to local environments. In this exploratory study, seven microbial isolates (Four fungal and three bacterial) were recovered from naturally infected Opisina arenosella exhibiting signs of mycosis. Their pathogenicity was evaluated under laboratory conditions against larvae of the red palm weevil (RPW, Rhynchophorus ferrugineus). Among the recovered isolates, a single fungal isolate was identified as Beauveria bassiana (Zeb-01) and showed greater virulence compared with the other isolates obtained in this study. Morphological characterization using light and scanning electron microscopy, combined with molecular identification based on ITS and EF1-α sequencing, confirmed the identity of Zeb-01 and described its hyphal and conidial features. In laboratory bioassays, Zeb-01 caused dose- and time-dependent mortality, reaching 85% larval and 86% adult mortality at 1.0 × 10¹⁰ conidia/mL within 10 days. At the lowest tested concentration (1.0 × 10⁶ conidia/mL), mortality rates of 35% and 50% were recorded for larvae and adults, respectively. When evaluated under the same experimental conditions alongside a commercial B. bassiana formulation, Zeb-01 exhibited lower LC₅₀ and LT₅₀ values. These results document the isolation, identification, and laboratory evaluation of a single native B. bassiana isolate recovered from O. arenosella, and demonstrate its entomopathogenic activity against RPW, indicating its potential relevance for integrated pest management programs (IPM).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.